Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Hummingbird Bioscience Exercises Its Option to License the Clinical Trial Results from Cancer Research UK to Support Further Development of HMBD-001 2023-03-06 21:00
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis 2023-03-06 20:00
Results of CLDN18.2-targeting Immuno-PET Probe for Non-invasive Imaging in Gastrointestinal Tumors Published 2023-03-03 14:56
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology 2023-03-02 20:00
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy 2023-03-02 20:00
Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376 2023-03-02 19:15
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network 2023-03-02 18:00
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow 2023-03-02 15:35
DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY 2023-03-02 09:00
ClinChoice Acquires CROMSOURCE, Expanding its Global Presence 2023-03-02 04:12
Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year 2023-03-01 19:00
GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting 2023-03-01 19:00
A promising picture for multi-cancer early detection in Southeast Asia - latest update from biotech firm Gene Solutions 2023-03-01 09:30
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND 2023-02-28 23:00
Global Cold Chain Transport Track & Trace Revenues in Pharma to Reach US$2.9 billion by 2027 2023-02-28 21:30
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products 2023-02-28 21:00
JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma 2023-02-28 17:30
Chula's AICute - An Assessment Tool for Ischemic Stroke Risk 2023-02-28 12:24
On Rare Disease Day 2023 RemeGen Highlights Its Social Responsibility and Rare Disease Advocacy 2023-02-28 09:16
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology 2023-02-28 08:53
1 83 84 85 86 87 377